Status:

COMPLETED

Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Collaborating Sponsors:

ANOCEF (french association of neuro-oncologists)

Conditions:

Newly-diagnosed Glioblastoma

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

To assess the efficacy of an Angiotensin-II inhibitor (Losartan) to reduce peritumoral edema in newly diagnosed glioblastoma patients.

Detailed Description

Multicentre, randomized (1:1), double blinded trial:- Arm A: Standard of care (Radiotherapy with concomitant temozolomide followed by monthly cures of temozolomide ) + Losartan 50mg\*2/day until the h...

Eligibility Criteria

Inclusion

  • 18 years or older
  • Histologically confirmed glioblastoma (Grade 4 WHO)
  • patients eligible for radiotherapy and concomitant Temozolomide
  • KPS ≥ 50%
  • Adequate hematologic, liver and renal functions

Exclusion

  • Patients unable to undergo an MRI with contrast
  • Patients without any residual tumor left on the screening MRI of both flair and contrast-enhanced lesions complete surgical resection)
  • Any prior treatment of glioblastoma including any local therapy (immunotherapy, Gliadel wafers, …..) during or after surgical resection
  • Any on-going treatment for high blood pressure at time of inclusion, whatever the therapeutic class of drugs
  • Systolic blood pressure \<110 mmHg.
  • relative or definite contra-indication to Losartan:
  • Pregnant or breast feeding women; Women with an intact uterus (unless amenorrhoeic for the last 24 months) not using effective means of contraception
  • Non-affiliation to the "sécurité sociale"

Key Trial Info

Start Date :

March 29 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 15 2017

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT01805453

Start Date

March 29 2013

End Date

May 15 2017

Last Update

May 8 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Neurology Department - Avicenne Hospital

Bobigny, France, 93000